Ophthalmology Doctors in Norwalk, CT Accepting Medicare

5 Ophthalmology doctors found. Showing 1 - 5

Dr. Peter Eugene Libre, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 111 East Ave, Suite 335, Norwalk, CT 06851 Phone: 203-853-2020    Fax: 203-852-9553

Dr. Scott M Spector, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 488 Main Ave Ste 2, Norwalk, CT 06851 Phone: 203-853-9000    Fax: 203-853-1359

Dr. Brad Evan Oren, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 East Ave Ste 335, Norwalk, CT 06851 Phone: 203-853-2020    Fax: 203-852-9553

Dr. Ding Martin Ma, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 761 Main Ave, Norwalk, CT 06851 Phone: 203-853-9900

Dr. James J. Y. Wong, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: C/o Connecticut Glaucoma Associates, 111 East Avenue, Suite 335, Norwalk, CT 06851 Phone: 203-856-7142    Fax: 203-226-3324

News Archive

CytomX collaborates with Pfizer to develop, commercialize more effective antibody-drug conjugates

CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has entered into a global strategic collaboration with Pfizer Inc. to develop and commercialize multiple Probody-Drug Conjugates.

MD Anderson creates new cancer-fighting grocery food list

Adults can avoid holiday weight gain by stocking up on the cancer-fighting foods listed in the new Holiday Food Grocery List, created by experts at The University of Texas MD Anderson Cancer Center.

"Best Doctors" survey finds NY Presbyterian has the most top doctors in metro area

For the eleventh straight year, NewYork-Presbyterian has more physicians listed in New York Magazine's "Best Doctors" survey than any other hospital. The magazine lists 191 NewYork-Presbyterian physicians representing 17 percent of the 1,144 New York City–area doctors listed.

Protox announces presentations on PRX302 for BPH at 2010 AUA Annual Meeting

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).

Graphic images of negative consequences of smoking have greatest impact on smokers

Marketing researchers at the University of Arkansas, Villanova University and Marquette University surveyed more than 500 U.S. and Canadian smokers and found that the highly graphic images of the negative consequences of smoking have the greatest impact on smokers' intentions to quit. The most graphic images, such as those showing severe mouth diseases, including disfigured, blackened and cancerous tissue, evoked fear about the consequences of smoking and thus influenced consumer intentions to quit.

Read more Medical News

› Verified 9 days ago